Trinity biotech announces application for early sjogrens syndrome test panel pla code

Dublin, ireland, feb. 07, 2024 (globe newswire) -- trinity biotech plc. (nasdaq: trib) (the “company”) today announced that its new york based reference laboratory, immco diagnostics, has applied for a proprietary laboratory analyses (pla) code for its early sjÖgrens syndrome test panel, to allow for an optimised market access strategy to deliver broader patient access and improved profitability.
TRIB Ratings Summary
TRIB Quant Ranking